RGLS logo

Regulus Therapeutics (RGLS) Return On Assets

Annual ROA

-97.68%
-37.05%-61.11%

December 31, 2023


Summary


Performance

RGLS ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

Quarterly ROA

-48.58%
+0.79%+1.60%

September 30, 2024


Summary


Performance

RGLS Quarterly ROA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

High & Low

Earnings dates

OtherRGLSprofitabilitymetrics:

ROA Formula

ROA =  Net Income
Total Assets
✕ 100%

RGLS ROA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-61.1%+1.6%
3 y3 years-147.4%+7.4%
5 y5 years-6.0%+43.4%

RGLS ROA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year-140.5%at lowat high+39.7%
5 y5-year-147.4%at low-25.8%+39.7%
alltimeall time-492.7%at low-580.4%+49.8%

Regulus Therapeutics ROA History

DateAnnualQuarterly
Sep 2024
-
-48.58%(-1.6%)
Jun 2024
-
-49.37%(-11.0%)
Mar 2024
-
-55.45%(-31.2%)
Dec 2023
-97.68%(+61.1%)
-80.55%(+15.6%)
Sep 2023
-
-69.70%(+9.8%)
Jun 2023
-
-63.50%(+5.0%)
Mar 2023
-
-60.46%(+14.3%)
Dec 2022
-60.63%(+49.3%)
-52.91%(+8.8%)
Sep 2022
-
-48.61%(-7.3%)
Jun 2022
-
-52.45%(+2.1%)
Mar 2022
-
-51.38%(-7.2%)
Dec 2021
-40.62%(+2.9%)
-55.38%(+7.0%)
Sep 2021
-
-51.76%(+34.1%)
Jun 2021
-
-38.61%(-17.8%)
Mar 2021
-
-46.98%(+2.6%)
Dec 2020
-39.48%(-25.7%)
-45.78%(-26.2%)
Sep 2020
-
-62.01%(-17.7%)
Jun 2020
-
-75.34%(+2.1%)
Mar 2020
-
-73.82%(+8.8%)
Dec 2019
-53.11%(-42.4%)
-67.86%(-20.9%)
Sep 2019
-
-85.84%(-0.3%)
Jun 2019
-
-86.11%(-7.1%)
Mar 2019
-
-92.72%(-4.2%)
Dec 2018
-92.13%
-96.74%(+11.5%)
Sep 2018
-
-86.75%(-1.4%)
Jun 2018
-
-88.00%(-3.4%)
DateAnnualQuarterly
Mar 2018
-
-91.09%(+4.2%)
Dec 2017
-80.58%(+19.0%)
-87.40%(+1.5%)
Sep 2017
-
-86.12%(+3.7%)
Jun 2017
-
-83.01%(+14.3%)
Mar 2017
-
-72.64%(+9.4%)
Dec 2016
-67.70%(+89.8%)
-66.42%(+26.8%)
Sep 2016
-
-52.39%(+16.1%)
Jun 2016
-
-45.12%(+5.1%)
Mar 2016
-
-42.92%(+18.7%)
Dec 2015
-35.67%(-7.3%)
-36.15%(-24.9%)
Sep 2015
-
-48.15%(+0.5%)
Jun 2015
-
-47.90%(+11.2%)
Mar 2015
-
-43.06%(-3.3%)
Dec 2014
-38.49%(+133.6%)
-44.52%(+45.5%)
Sep 2014
-
-30.59%(+24.1%)
Jun 2014
-
-24.65%(+15.7%)
Mar 2014
-
-21.31%(+24.8%)
Dec 2013
-16.48%(-30.7%)
-17.07%(-32.9%)
Sep 2013
-
-25.43%(-31.2%)
Jun 2013
-
-36.98%(+13.3%)
Mar 2013
-
-32.63%(+3.3%)
Dec 2012
-23.78%(+34.1%)
-31.60%(-2.0%)
Sep 2012
-
-32.23%(+55.0%)
Jun 2012
-
-20.79%(+67.9%)
Mar 2012
-
-12.38%(+73.4%)
Dec 2011
-17.73%
-7.14%

FAQ

  • What is Regulus Therapeutics annual return on assets?
  • What is the all time high annual ROA for Regulus Therapeutics?
  • What is Regulus Therapeutics annual ROA year-on-year change?
  • What is Regulus Therapeutics quarterly return on assets?
  • What is the all time high quarterly ROA for Regulus Therapeutics?
  • What is Regulus Therapeutics quarterly ROA year-on-year change?

What is Regulus Therapeutics annual return on assets?

The current annual ROA of RGLS is -97.68%

What is the all time high annual ROA for Regulus Therapeutics?

Regulus Therapeutics all-time high annual return on assets is -16.48%

What is Regulus Therapeutics annual ROA year-on-year change?

Over the past year, RGLS annual return on assets has changed by -37.05% (-61.11%)

What is Regulus Therapeutics quarterly return on assets?

The current quarterly ROA of RGLS is -48.58%

What is the all time high quarterly ROA for Regulus Therapeutics?

Regulus Therapeutics all-time high quarterly return on assets is -7.14%

What is Regulus Therapeutics quarterly ROA year-on-year change?

Over the past year, RGLS quarterly return on assets has changed by +0.79% (+1.60%)